Comparison of MRI with liverspecific contrast agents and multidetector row CT for the detection of hepatocellular carcinoma: A meta-analysis of 15 direct comparative studies

Gut

Volumn 62, Issue 10, 2013, Pages 1520-1521

  Chen, Lihua ^a,b   Zhang, Lin ^a   Bao, Jing ^c   Zhang, Jiuquan ^a   Li, Chuanming ^a   Xia, Yunbao ^b   Huang, Xuequan ^a   Wang, Jian ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Taihu Hospital   (China)

^c Wuxi Center for Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GADOXETIC ACID; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; GLUTAMATE AMMONIA LIGASE; GLYPICAN; HEAT SHOCK PROTEIN 70; TUMOR MARKER;

AREA UNDER THE CURVE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; EVIDENCE BASED MEDICINE; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; META ANALYSIS; MULTIDETECTOR COMPUTED TOMOGRAPHY; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TISSUE SPECIFICITY; TUMOR VOLUME; COMPUTER ASSISTED TOMOGRAPHY; EARLY DIAGNOSIS; FEMALE; HEPATOBILIARY RADIOLOGY; LIVER TUMOR; MALE; METABOLISM; METHODOLOGY; CARCINOMA, HEPATOCELLULAR; LIVER NEOPLASMS; PROCEDURES;

COMPUTER TOMOGRAPHY; HEPATOBILIARY RADIOLOGY; HEPATOCELLULAR CARCINOMA; MAGNETIC RESONANCE IMAGING; META-ANALYSIS;

CARCINOMA, HEPATOCELLULAR; EARLY DETECTION OF CANCER; FEMALE; GLUTAMATE-AMMONIA LIGASE; GLYPICANS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; LIVER NEOPLASMS; MALE; TUMOR MARKERS, BIOLOGICAL;

EID: 84884215790     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-305231     Document Type: Note

References (12)

1. Tremosini S, Forner A, Boix L, et al. Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma. Gut 2012;61:1481-7.
2. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020-2.
3. European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. Eur J Cancer 2012;48:599-641.
4. Ba-Ssalamah A, Uffmann M, Saini S, et al. Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions. Eur Radiol 2009;19:342-57.
5. Colli A, Fraquelli M, Casazza G, et al. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol 2006;101:513-23. (Pubitemid 43340927)
6. Floriani I, D'Onofrio M, Rulli E, et al. Performance of imaging modalities in the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Ultraschall Med. Published Online First: 13 Dec. 2012. doi:10.1055/s-0032-1330358
7. Golfieri R, Marini E, Bazzocchi A, et al. Small (< or=3 cm) hepatocellular carcinoma in cirrhosis: the role of double contrast agents in MR imaging vs. multidetector-row CT. Radiol Med 2009;114:1239-66.
8. Sun HY, Lee JM, Shin CI, et al. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging. Invest Radiol 2010;45:96-103.
9. Sano K, Ichikawa T, Motosugi U, et al. Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging. Radiology 2011;261:834-44.
10. Haradome H, Grazioli L, Tinti R, et al. Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging. J Magn Reson Imaging 2011;34:69-78.
11. Park MJ, Kim YK, Lee MH, et al. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<=2.0 cm) in patients with hepatitis-induced liver cirrhosis. Acta Radiol 2013;54:127-36.
12. Ayyappan AP, Jhaveri KS. CT and MRI of hepatocellular carcinoma: an update. Expert Rev Anticancer Ther 2010;10:507-19.